Risk of transfusion-related acute lung injury and human immunodeficiency virus associated with donations from trans donors in Quebec, Canada

Vox Sang. 2022 Sep;117(9):1070-1077. doi: 10.1111/vox.13299. Epub 2022 Jun 5.

Abstract

Background and objectives: Blood operator must establish selection criteria according to the populations at risk of blood-related infections and complications. Therefore, this study aimed to assess the risks of transfusion-related acute lung injury (TRALI) and human immunodeficiency virus (HIV) associated with donations from trans persons.

Materials and methods: Donor screening data from Héma-Québec were used. The risks of TRALI and HIV were estimated based on internal data and assumptions derived from the literature. The risk was assessed under four scenarios: a most likely scenario, an optimistic scenario and two pessimistic scenarios. All scenarios assumed no prior screening for trans donors.

Results: The trans population comprised 134 donors, including 94 (70.1%) trans men. Of the 134 donors, 58 (43.3%) were deferred from donating a blood-derived product because of an ongoing gender-affirming genital surgery, and the remaining 76 (56.7%) were eligible donors. The risk of having a TRALI-causing donation, given that it comes from a trans man, was estimated at one every 115-999 years for all scenarios. The risk of having an HIV-contaminated donation, given that it comes from a trans woman, was estimated at one every 1881-37,600 years for all scenarios.

Conclusion: This study suggests that donations from trans persons are associated with a negligible risk of TRALI and HIV.

Keywords: blood safety; risk analysis; trans donors; transfusion medicine; transfusion-transmissible infection.

MeSH terms

  • Blood Donors
  • Female
  • HIV
  • HIV Infections* / diagnosis
  • Humans
  • Male
  • Quebec
  • Transfusion-Related Acute Lung Injury*

Grants and funding